Logo image of STSS

SHARPS TECHNOLOGY INC (STSS) Stock Fundamental Analysis

USA - NASDAQ:STSS - US82003F3091 - Common Stock

6.7007 USD
-0.05 (-0.73%)
Last: 10/6/2025, 11:30:49 AM
Fundamental Rating

2

Taking everything into account, STSS scores 2 out of 10 in our fundamental rating. STSS was compared to 191 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for STSS as it has an excellent financial health rating, but there are worries on the profitability. STSS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year STSS has reported negative net income.
STSS had a negative operating cash flow in the past year.
STSS had negative earnings in each of the past 5 years.
STSS had a negative operating cash flow in each of the past 5 years.
STSS Yearly Net Income VS EBIT VS OCF VS FCFSTSS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M

1.2 Ratios

STSS's Return On Assets of -4.23% is fine compared to the rest of the industry. STSS outperforms 67.02% of its industry peers.
Looking at the Return On Equity, with a value of -4.97%, STSS is in the better half of the industry, outperforming 68.06% of the companies in the same industry.
Industry RankSector Rank
ROA -4.23%
ROE -4.97%
ROIC N/A
ROA(3y)-83.26%
ROA(5y)-86.74%
ROE(3y)-212.63%
ROE(5y)-179.23%
ROIC(3y)N/A
ROIC(5y)N/A
STSS Yearly ROA, ROE, ROICSTSS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

STSS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
STSS Yearly Profit, Operating, Gross MarginsSTSS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

7

2. Health

2.1 Basic Checks

The number of shares outstanding for STSS has been increased compared to 1 year ago.
The number of shares outstanding for STSS has been increased compared to 5 years ago.
STSS has a worse debt/assets ratio than last year.
STSS Yearly Shares OutstandingSTSS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2K 4K 6K
STSS Yearly Total Debt VS Total AssetsSTSS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

STSS has an Altman-Z score of 38.83. This indicates that STSS is financially healthy and has little risk of bankruptcy at the moment.
STSS has a better Altman-Z score (38.83) than 97.38% of its industry peers.
There is no outstanding debt for STSS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 38.83
ROIC/WACCN/A
WACCN/A
STSS Yearly LT Debt VS Equity VS FCFSTSS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M

2.3 Liquidity

A Current Ratio of 4.35 indicates that STSS has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.35, STSS is in the better half of the industry, outperforming 73.30% of the companies in the same industry.
A Quick Ratio of 3.67 indicates that STSS has no problem at all paying its short term obligations.
STSS has a Quick ratio of 3.67. This is in the better half of the industry: STSS outperforms 72.25% of its industry peers.
Industry RankSector Rank
Current Ratio 4.35
Quick Ratio 3.67
STSS Yearly Current Assets VS Current LiabilitesSTSS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

0

3. Growth

3.1 Past

STSS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 67.39%, which is quite impressive.
EPS 1Y (TTM)67.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.56%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-633.33%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-95.06%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
STSS Yearly Revenue VS EstimatesSTSS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 10B 20B 30B
STSS Yearly EPS VS EstimatesSTSS Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 -1K -2K -3K -4K

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for STSS. In the last year negative earnings were reported.
Also next year STSS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
STSS Price Earnings VS Forward Price EarningsSTSS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
STSS Per share dataSTSS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -200 -400 -600 -800 -1K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

STSS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SHARPS TECHNOLOGY INC

NASDAQ:STSS (10/6/2025, 11:30:49 AM)

6.7007

-0.05 (-0.73%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-14 2024-05-14/amc
Earnings (Next)N/A N/A
Inst Owners0.07%
Inst Owner Change0%
Ins Owners0.08%
Ins Owner Change40.59%
Market Cap178.24M
Analysts82.86
Price Target22.44 (234.89%)
Short Float %1.25%
Short Ratio0.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-93.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 800.35
P/FCF N/A
P/OCF N/A
P/B 12.26
P/tB 12.29
EV/EBITDA N/A
EPS(TTM)-1065.01
EYN/A
EPS(NY)-1.12
Fwd EYN/A
FCF(TTM)-0.37
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS0.01
BVpS0.55
TBVpS0.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.23%
ROE -4.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-83.26%
ROA(5y)-86.74%
ROE(3y)-212.63%
ROE(5y)-179.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 317.25%
Cap/Sales 933.36%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.35
Quick Ratio 3.67
Altman-Z 38.83
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)192.36%
Cap/Depr(5y)2248.75%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)67.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.56%
EPS Next Y-633.33%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-95.06%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y6.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3.82%
OCF growth 3YN/A
OCF growth 5YN/A